What makes ARA-290 different ARA-290 was engineered from the tissue-protective domain of erythropoietin (EPO)
It was shown that DEFA1 displays a broad spectrum of antimicrobial activity against both fermenting and non-fermenting Gram-negative strains, against Gram-positive cocci, spore-forming bacilli, and the yeast Candida (C.) albicans
In an experimental study performed in 5/6 nephrectomized normo- and hyperuricemic rats, febuxostat protected against renal damage, and prevented proteinuria, preserving vessel morphology and glomerular pressure, thus it prevents progression of CKD independently of its effect on UA.46 In the FOCUS47 extension study, 116 patients treated with febuxostat were followed for 5 years
A total of 12 most potential off-target sites were predicted across the sheep genome
Presence of glucagon and glucagon-like peptide-1-(7-36)amide receptors in solubilized membranes of human adipose tissue